U.S., May 7 -- ClinicalTrials.gov registry received information related to the study (NCT06958783) titled 'Chemotherapy-induced Lipid Profile Changes in Women With Early Breast Cancer' on April 27.
Brief Summary: Detection of changes in the lipid profile in early-stage breast cancer patients undergoing neoadjuvant or adjuvant chemotherapy with doxorubicin, cyclophosphamide, and paclitaxel.
Study Start Date: March 05, 2023
Study Type: OBSERVATIONAL
Condition:
Breast Neoplasms, Neoadjuvant Therapy, Lipid Metabolism, Dyslipidemias, Cardiovascular Diseases
Intervention:
OTHER: Blood lipid monitoring in breast cancer patients during chemotherapy
This intervention is distinguished by its prospective design, enrollment of a clearly defined...